Thus, compounds such as etifoxine and GD-23 that target TSPO show potential as novel non-benzodiazepine treatments for anxiety [34,35,58], given their role in neurosteroid synthesis and the modulation of neuroinflammation. Here, TSPO is linked to Anxiety.